ESMO-Magnitude of Clinical Benefit Scale versions 1.0 and 1.1
The ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) version 1.0 (v1.0) published in May 2015 and was the first version of this validated and reproducible tool to assess the magnitude of clinical benefit from new cancer therapies. The ESMO-MCBS is designed to be a dynamic tool with planned revisions and updates based upon recognition of expanding needs and shortcomings identified.
The revised ESMO-MCBS v1.1 incorporates 10 revisions and allows for scoring of single-arm studies.
The 2015 and 2017 articles can both be found in Annals of Oncology to view the articles please select below: